These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30633768)

  • 41. Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapy.
    Kloosterman M; Rienstra M; Mulder BA; Van Gelder IC; Maass AH
    Europace; 2016 Aug; 18(8):1211-9. PubMed ID: 26718536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
    Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
    JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
    St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
    Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An exploratory study on coronary sinus lead tip three-dimensional trajectory changes in cardiac resynchronization therapy.
    Tomasi C; Corsi C; Turco D; Severi S
    Heart Rhythm; 2013 Sep; 10(9):1360-7. PubMed ID: 23851066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cardiac resynchronization therapy in patients with permanent atrial fibrillation].
    Mareev IuV; Shitov VN; Kiktev VG; Sapel'nikov OV; Latypov RS; Grishin IR; Malkina TA; Nesterenko LIu; Iuricheva IuA; Sokolov SF; Saidova MA; Akchurin RS; Golitsyn SP
    Kardiologiia; 2013; 53(5):43-9. PubMed ID: 23952994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.
    Birnie D; Hudnall H; Lemke B; Aonuma K; Lee KL; Gasparini M; Gorcsan J; Cerkvenik J; Martin DO
    Heart Rhythm; 2017 Dec; 14(12):1820-1825. PubMed ID: 28893549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
    St John Sutton M; Linde C; Gold MR; Abraham WT; Ghio S; Cerkvenik J; Daubert JC;
    JACC Heart Fail; 2017 Mar; 5(3):169-178. PubMed ID: 28254122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.
    Plummer CJ; Frank CM; Bári Z; Al Hebaishi YS; Klepfer RN; Stadler RW; Ghosh S; Liu S; Mittal S
    Heart Rhythm; 2018 Mar; 15(3):369-375. PubMed ID: 29132930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy.
    Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
    Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
    Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Echocardiographic and clinical response to cardiac resynchronization therapy in heart failure patients with and without previous right ventricular pacing.
    Gage RM; Burns KV; Bank AJ
    Eur J Heart Fail; 2014 Nov; 16(11):1199-205. PubMed ID: 25132044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.
    Boriani G; Kranig W; Donal E; Calo L; Casella M; Delarche N; Lozano IF; Ansalone G; Biffi M; Boulogne E; Leclercq C;
    Am Heart J; 2010 Jun; 159(6):1052-1058.e1. PubMed ID: 20569719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.
    Kiès P; Leclercq C; Bleeker GB; Crocq C; Molhoek SG; Poulain C; van Erven L; Bootsma M; Zeppenfeld K; van der Wall EE; Daubert JC; Schalij MJ; Bax JJ
    Heart; 2006 Apr; 92(4):490-4. PubMed ID: 16159986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Narrowing filtered QRS duration on signal-averaged electrocardiogram predicts outcomes in cardiac resynchronization therapy patients with nonischemic heart failure.
    Suzuki A; Shiga T; Yagishita D; Yagishita-Tagawa Y; Arai K; Iwanami Y; Ejima K; Ashihara K; Shoda M; Hagiwara N
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12523. PubMed ID: 29194868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positive impact of pulmonary vein isolation on biventricular pacing in nonresponders to cardiac resynchronization therapy.
    Fink T; Rexha E; Schlüter M; Lemes C; Maurer T; Heeger CH; Reissmann B; Rottner L; Tönnis T; Ujeyl A; Krüger M; Portz N; Wohlmuth P; Mathew S; Ouyang F; Rillig A; Kuck KH; Metzner A
    Heart Rhythm; 2019 Mar; 16(3):416-423. PubMed ID: 30273766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies.
    Ciconte G; Ćalović Ž; McSpadden LC; Ryu K; Mangual J; Caporaso I; Baldi M; Saviano M; Cuko A; Vitale R; Conti M; Giannelli L; Vicedomini G; Santinelli V; Pappone C
    J Interv Card Electrophysiol; 2019 Mar; 54(2):141-149. PubMed ID: 30483980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.
    Borleffs CJ; Ypenburg C; van Bommel RJ; Delgado V; van Erven L; Schalij MJ; Bax JJ
    Heart Rhythm; 2009 Mar; 6(3):305-10. PubMed ID: 19251202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.